SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Further, ICAR-IVRI have jointly developed a Lumpy Skin Disease vaccine and as soon as the technology is made available, Hester will acquire the same and manufacture and commercialize the Lumpy Skin disease Vaccine
NATCO estimates the current market size of CTPR containing products in India to be over Rs. 2,000 crore.
The companies will leverage their respective proprietary technology platforms
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
The startup plans to provide free technology to dental clinics upon registration.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Subscribe To Our Newsletter & Stay Updated